Navigation Links
BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
Date:12/4/2012

NEW YORK, Dec. 4, 2012 /PRNewswire/ -- RetailInvestorConferences.com is pleased to announce that BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, will present at RetailInvestorConferences.com. BioSpecifics' President Tom L. Wegman will be speaking directly to investors.

DATE:  

December 6, 2012

TIME:   

3:00 PM EST

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. (Nasdaq GM: BSTC) is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Injectable collagenase is currently marketed as XIAFLEX® in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is approved for Dupuytren's contracture in the European Union and Canada. XIAFLEX is also in clinical development for the treatment of several additional promising indications: Auxilium recently submitted a supplemental Biologics License Application (sBLA) to the FDA for XIAFLEX for the potential treatment of Peyronie's disease based on positive results reported from its two Phase III clinical studies. Auxilium is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials. Auxilium is currently partnered with Asahi Kasei Pharma Corporation for the development and commercialization of injectable collagenase for Dupuytren's contracture and Peyronie's disease in Japan and with Actelion Pharmaceuticals Ltd. for these same indications in Canada, Australia, Brazil and Mexico. Pfizer Inc. has marketing rights to XIAPEX® (the EU trade name for XIAFLEX) for Dupuytren's contracture in 46 countries in Eurasia through April 24, 2013.  For more information, please visit www.biospecifics.com.

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE RetailInvestorConferences.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
2. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
5. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
6. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
7. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
8. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
9. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
10. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
11. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... ... December 04, 2019 , ... The Harm Reduction Institute ... Orange County drug and alcohol rehab center and non-profit Intensive outpatient ... team conducted street outreach, trained, and distributed Naloxone amongst members of the own community ...
(Date:12/4/2019)... ... December 04, 2019 , ... Intelligent.com, a trusted resource for ... in Organizational Psychology Degree Programs for 2020. The comprehensive research guide is based ... program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. ...
(Date:12/2/2019)... ... December 02, 2019 , ... TopConsumerReviews.com recently awarded their highest ... at supporting Women’s Fertility and healthy natural ovulation. , Millions of couples long ... than for others. Factors like weight, medical conditions, age, and even stress can ...
Breaking Medicine Technology:
(Date:12/9/2019)... ... 2019 , ... Cocoa Beach is preparing to host its 10th annual “Surfing ... gatherings. , What began as a simple family beach day a decade ago has ... ten years in, there’s no better place for Santa to loosen up as he ...
(Date:12/8/2019)... ... , ... Intelligent.com, a trusted resource for online degree rankings ... 2020. The comprehensive research guide is based on an assessment of 104 accredited ... quality, graduation rate, reputation, and post-graduate employment. , The 2020 rankings are ...
(Date:12/6/2019)... , ... December 06, 2019 , ... ... of assembling and manufacturing implantable medical devices, which is a new and rapidly ... name suggests, implantable medical devices are surgically inserted into various parts of the ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... Allegheny Health ... , Dr. Gyure, who joined AHN from WVU Medicine in May 2018, previously served ... She has served as interim chair since October and is also part of the ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... healthcare professionals in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals ... , 1. Understand methods of quantitative sEMG analysis during ictal events;, 2. Review ...
Breaking Medicine News(10 mins):